From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors

(2022) Emir Muzurović et al.   HYPERTENSION

Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study

(2022) Hexiang Peng et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Perivascular Adipose Tissue: Pathophysiological Links With Inflammation, Atherosclerosis, and Thrombosis

(2021) Niki Katsiki et al.   ANGIOLOGY

Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease

(2021) Chander K. Negi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease

(2020) Nikolaos Perakakis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Perirenal Adiposity and Other Excessive Intra- and Peri-Organ Fat Depots: What Is the Connection?

(2019) Niki Katsiki et al.   ANGIOLOGY

Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement

(2019) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study

(2019) Nikolaos Perakakis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Abnormal Peri-Organ or Intra-Organ Fat Deposition and Vascular Risk

(2018) Niki Katsiki et al.   ANGIOLOGY

Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?

(2018) Niki Katsiki et al.   Current Vascular Pharmacology

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

(2018) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY